Contrast Medium Use in Computed Tomography for Patients Presenting with Headache: 4-year Retrospective Two-Center Study in Central and Western Regions of Ghana
Table 3
Head CT findings and contrast enhancement among patients with headache, 2017–2020.
CT findings
With contrast
Without contrast
Logistics regression
Number (n)
#Percentage (%)
Number (n = 36)
#Percentage (%)
OR (95% CI)
-value
Sinusitis
98
59.0
22
61.1
0.92 (0.44–1.92)
0.818
Hydrocephalus/edema
12
7.23
3
8.3
0.86 (0.23–3.21)
0.819
Hemorrhage
21
12.7
3
8.3
1.59 (0.45–5.66)
0.471
Meningitis
5
3.0
0
0.0
—
—
Tumor/metastasis/cyst
40
24.1
11
30.6
0.72 (0.33–1.60)
0.420
Infarct
11
6.6
3
8.3
0.78 (0.21–2.95)
0.715
Brain atrophy
8
4.8
0
0.0
—
—
Bone-related pathology
3
1.8
1
2.8
0.64 (0.07–6.38)
0.707
Ischemic small vessel
5
3.0
3
8.3
0.34 (0.08–1.50)
0.155
Calcifications
3
1.8
1
2.8
0.64 (0.07–6.38)
0.707
oOther CT findings
7
4.2
1
2.8
1.54 (0.83–12.93)
0.690
Φ Other CT findings include mastoiditis (3), thrombosis (1) diffuse deep white matter (1), enlarged tonsils (1), and herniation (1); # the total is more than 100%, one patient could be diagnosed of multiple pathologies.
